March 24 (Reuters) - United Laboratories International Holdings Ltd 3933.HK:
ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT WITH NOVO NORDISK
AGREEMENT FOR UBT251
UNITED BIOTECHNOLOGY IS ELIGIBLE TO RECEIVE AN UPFRONT PAYMENT OF US$200 MILLION
UNITED BIOTECHNOLOGY IS ELIGIBLE TO RECEIVE POTENTIAL MILESTONE PAYMENTS OF UP TO US$1.8 BILLION
Further company coverage: 3933.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.